LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Jasper Therapeutics, Inc. ("Jasper†or the "Company†) (NASDAQ: JSPR) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON JASPER THERAPEUTICS, INC. (JSPR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 7, 2025, Jasper released an update on its Phas. ...

诉讼背景 - Levi & Korsinsky律所代表在2025年7月15日至8月14日期间遭受损失的Fly-E投资者提起集体诉讼[1] - 诉讼指控公司在此期间实施证券欺诈行为[1] 指控内容 - 公司发布过于乐观的声明同时传播 materially false and misleading statements[2] - 公司隐瞒锂电池安全问题的 material adverse facts[2] - 锂电池安全问题对电动车辆销售 revenue 产生 material toll[2] - 尽管做出 lofty long-term projections 但预测流程存在缺陷[2] - 销售持续下滑且运营费用增加[2] 财务影响 - 2026财年第一季度净收入大幅下降32% primarily driven by a decrease in total units sold[2] - 收入下降 attributed to recent lithium-battery accidents involving E-Bikes and E-Scooters[2] - 股价从2025年8月14日收盘价7.76美元暴跌至次日1.00美元[2] - 单日股价跌幅达87%[2] 公司业务 - Fly-E Group Inc 主要从事电动自行车和电动滑板车业务[2] - 公司产品使用锂电池技术[2] - 锂电池安全事故对公司销售产生重大负面影响[2]

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Charter Communications, Inc. ("Charter Communications, Inc." or the "Company") (NASDAQ: CHTR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Charter Communications, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons and entities who purchased or otherwise acquired Charter securities, purchased call opt ...

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Snap Inc. ("Snap" or the "Company") (NYSE: SNAP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Snap investors who were adversely affected by alleged securities fraud between April 29, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=168 ...

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lockheed Martin Corporation ("Lockheed Martin Corporation" or the "Company") (NYSE: LMT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lockheed Martin Corporation investors who were adversely affected by alleged securities fraud between January 23, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team: htt ...

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/savara-inc-lawsuit-submissio ...

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in V.F. Corporation ("V.F. Corporation" or the "Company") (NYSE: VFC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of V.F. Corporation investors who were adversely affected by alleged securities fraud between October 30, 2023 and May 20, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/v-f-corporati ...

集体诉讼背景 - 集体诉讼代表在2023年11月30日至2025年7月3日期间购买或收购Jasper Therapeutics公司证券的个人和实体提起 [1] - Jasper Therapeutics是一家临床阶段生物技术公司，专注于开发针对肥大细胞驱动疾病的疗法，如慢性自发性荨麻疹、慢性诱导性荨麻疹和哮喘 [1] 指控内容 - 公司被指控未能披露其缺乏必要的控制和程序，以确保所依赖的第三方制造商完全按照cGMP法规生产产品并适用于临床试验 [2] - 上述失败增加了正在进行的临床研究结果被混淆的风险，从而对包括briquilimab在内的公司产品的监管和商业前景产生负面影响 [2] - 上述情况增加了采取破坏性成本削减措施的可能性，因此公司的业务和/或财务前景以及briquilimab的临床和/或商业前景被夸大 [2] 市场影响 - 2025年7月7日真相披露后，公司股价下跌每股3.73美元，跌幅达55.1%，报收于每股3.04美元 [3]

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Flywire Corporation ("Flywire Corporation" or the "Company") (NASDAQ: FLYW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Flywire Corporation investors who were adversely affected by alleged securities fraud between February 28, 2024 and February 25, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/psl ...

诉讼核心指控 - 针对C3ai及其高级管理层的集体诉讼指控其违反1934年证券交易法并误导投资者关于公司财务健康状况和增长前景[1] - 诉讼指控公司对营收和增长潜力的预测过于乐观且其关于增长和盈利能力的公开声明被指不切实际[2] - 诉讼焦点在于公司未能充分披露首席执行官Thomas M Siebel的健康问题对公司达成交易和实现财务目标能力的影响[2][5] 股价与财务表现 - 公司在2025年8月8日公布低于预期的初步第一季度业绩并下调了全年营收指引[3] - 公司将令人失望的业绩归因于新领导层的重组以及首席执行官的健康问题[3] - 此财务公告后公司股价暴跌超过25%[3] 诉讼程序细节 - 诉讼拟代表在2025年2月26日至2025年8月8日期间购买或收购C3ai证券的投资者[2][4] - 遭受重大损失并有兴趣作为首席原告的投资者必须在2025年10月21日前向法院提交动议[2][4]